Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Inaglimet 2.5mg/850mg


Contraindicated

Contraindicated
Inaglimet 2.5mg/850mg :
Type Medicine Authorised
Originator Jentadueto 2.5mg/850mg
Agent Pharmaline
Distributor Pharmaline
Laboratory Pharmaline Laboratories
Manufacturer Pharmaline SAL*
Manufacturing Type G
Origin Lebanon
ATC A10BD11

Your comment will appear shortly after approval

Inaglimet 2.5mg/850mg :

Revision Date : 27/05/2015


Effect Frequency
Abdominal pain Very Common
Amylase increased Uncommon
Anaemia megaloblastic Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Bronchial hyperreactivity Rare
Constipation Uncommon
Cough Uncommon
Decreased appetite Uncommon
Diarrhoea (Diarrhea) Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Erythema Very rare
Hepatic function disorder Common
Hepatitis Very rare
Hypersensitivity Rare
Hypoglycaemia Very Common
Lactic acidosis Very rare
Nasopharyngitis Uncommon
Nausea Uncommon
Pancreatitis Not known
Pruritus Uncommon
Skin rash Uncommon
Skin reaction Very rare
Urticaria Rare
Vitamin B12 deficiency Very rare
Vomiting Uncommon

Different Units By MoH Code

Revision Date : 01/10/2021

Inaglimet 2.5mg/850mg  MoH 10766 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 60
Strength 2.5mg/850mg
Public Price 1670844,18 L.L.
Stratum B
NSSF ✘
Quarantine ✘
Reg. Number 58120/1
Submission date 19/05/2020
Registration Year 09/11/2021
Pending Year 16/09/2020


Price Comparison

● Country: Lebanon
● Form: Tablet, Film-Coated
● Package Size: Box of 60
● Public Price: 1670844.18 LBP ( 1,670,844.18 LBP )
● Pack size unit used: 60
● Cost/Unit: 27847,4 LBP ( 27,847.00 LBP )
● Pricing Date: 10/11/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info